Jan 23, 2019 - Results from a few clinical trials reading out in 2019 could make it a year to remember.
Jan 11, 2019 - Lilly (LLY) is spending $8 billion to buy small cancer biotech Loxo Oncology. Big Pharma CEOs hint at spur in M&A activity in 2019.
Jan 11, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Jan 11, 2019 - Here we present four therapeutic areas whose pipeline developments are expected to garner a lot of interest in 2019.
Jan 10, 2019 - Big pharma CEOs hint at spur in M&A activity in 2019 at the 37th J.P. Morgan Healthcare Conference.
Jan 08, 2019 - Following two blockbuster merger and acquisition deals, a rise in M&A activity in the pharma space is likely led by consolidation in the cancer space.
Jan 07, 2019 - In an interview with CNBC's Jim Cramer, GlaxoSmithKline (GSK +0.7%) CEO Emma Walmsley says there are "tremendous opportunities" to improve operating performance, adding that the company will g
Jan 04, 2019 - Merck (MRK) exercises option to in-license an insulin sensitizer from NGM Biopharmaceuticals for NASH and type II diabetes. Its key drug Keytruda snaps up five new label expansion nods in Japan.
Jan 02, 2019 - Top Research Reports for Facebook, Wells Fargo & AT&T
Dec 31, 2018 - Novartis (NVS) gets a boost from strong performance of new drugs. Strategic acquisitions to foray into promising areas has also boosted investor sentiment.